GlaxoSmithKline Inc. / Business-Led Networks / Boehringer Ingelheim (Canada) Ltd. / OCE / Novartis Pharmaceuticals Canada Inc. / Merck / Eli Lilly Canada Inc. / CQDM / AstraZeneca / Pfizer Canada / /
Country
Canada / /
Currency
USD / / /
Event
Business Partnership / /
IndustryTerm
disruptive technology / transportation / technology innovations / biopharmaceutical research leading / drug discovery technologies / communications technology / energy / pharmaceutical research / digital media / agri-food / mining / manufacturing / biopharmaceutical research / /
Organization
Government of Ontario / Quebec government / /
Person
Reza Moridi / Diane Gosselin / Life Sciences / Min / Tom Corr / Life Sciences Ontario / Josée Fortin / Pierre Duchesne / Jason Field / / /
Position
Minister of Research / Executive Director / Minister / Director General / President and CEO / Annual General / /
ProvinceOrState
Quebec / Ontario / /
PublishedMedium
la Recherche / /
Technology
communications technology / drug discovery technologies / Drug Discovery / /
NEWS RELEASE Drug-enabling technology innovations get boost through OCE-CQDM Life Sciences R&D challenge MONTREAL, Oct. 30, 2013 – Ontario Centres of Excellence (OCE) and the Québec Consortium for Drug Discovery (CQD